Abdulelah Ahmed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Abdulelah Ahmed has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Arin Bhattacharjee
Pharmacology and Toxicology, University at Buffalo - The State University of New York, Buffalo, USA
1 shared publication Garrett D. Sheehan
Program for Neuroscience, University at Buffalo - The State University of New York, Buffalo, USA
1 shared publication- Kerri D. Pryce
Nash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
1 shared publication Kwaku Bonsu
Pharmacology and Toxicology, University at Buffalo - The State University of New York, Buffalo, USA
1 shared publication- Rasheen Powell
F.M. Kirby Neurobiology Center, Boston Children’s Hospital, and Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA
1 shared publication Violet A. Young
Program for Neuroscience, University at Buffalo - The State University of New York, Buffalo, USA
1 shared publication
Latest Publications
- Open Access
- 4 October 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-15
Inhibiting endocytosis in CGRP+ nociceptors attenuates inflammatory pain-like behavior
The advantage of locally applied anesthetics is that they are not associated with the many adverse effects, including addiction liability, of systemically administered analgesics. This therapeutic approach has two inherent pitfalls: specificity and a short duration of action. Here, we identified nociceptor endocytosis as a promising target for local, specific, and long-lasting treatment of inflammatory pain. We observed preferential expression of AP2α2, an α-subunit isoform of the AP2 complex, within CGRP+/IB4- nociceptors in rodents and in CGRP+ dorsal root ganglion neurons from a human donor. We utilized genetic and pharmacological approaches to inhibit nociceptor endocytosis demonstrating its role in the development and maintenance of acute and chronic inflammatory pain. One-time injection of an AP2 inhibitor peptide significantly reduced acute and chronic pain-like behaviors and provided prolonged analgesia. We evidenced sexually dimorphic recovery responses to this pharmacological approach highlighting the importance of sex differences in pain development and response to analgesics.
- 4 October 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-15
Open AccessInhibiting endocytosis in CGRP+ nociceptors attenuates inflammatory pain-like behavior
The advantage of locally applied anesthetics is that they are not associated with the many adverse effects, including addiction liability, of systemically administered analgesics. This therapeutic approach has two inherent pitfalls: specificity and a short duration of action. Here, we identified nociceptor endocytosis as a promising target for local, specific, and long-lasting treatment of inflammatory pain. We observed preferential expression of AP2α2, an α-subunit isoform of the AP2 complex, within CGRP+/IB4- nociceptors in rodents and in CGRP+ dorsal root ganglion neurons from a human donor. We utilized genetic and pharmacological approaches to inhibit nociceptor endocytosis demonstrating its role in the development and maintenance of acute and chronic inflammatory pain. One-time injection of an AP2 inhibitor peptide significantly reduced acute and chronic pain-like behaviors and provided prolonged analgesia. We evidenced sexually dimorphic recovery responses to this pharmacological approach highlighting the importance of sex differences in pain development and response to analgesics.